Observational studyBlood advances2026
Polatuzumab vedotin-containing regimens as bridge to CART: analysis from the CART-SIE study.
Giulia Gabrielli et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it